These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36282951)

  • 21. Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium.
    Chace DH; DiPerna JC; Naylor EW
    Acta Paediatr Suppl; 1999 Dec; 88(432):45-7. PubMed ID: 10626577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of mass spectrometry to analyze dried blood spots.
    Wagner M; Tonoli D; Varesio E; Hopfgartner G
    Mass Spectrom Rev; 2016; 35(3):361-438. PubMed ID: 25252132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.
    Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S
    Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in laboratory hematology reflected by a decade of
    Hoffmann JJML; Urrechaga E
    Clin Chem Lab Med; 2023 Apr; 61(5):829-840. PubMed ID: 36285728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical application of mass spectrometry in the pediatric field: current topics].
    Yamaguchi S
    Rinsho Byori; 2013 Sep; 61(9):817-25. PubMed ID: 24369594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass Spectrometry and Microbial Diagnostics in the Clinical Laboratory.
    Cox CR; Harris RM
    Clin Lab Med; 2021 Jun; 41(2):285-295. PubMed ID: 34020764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tandem mass spectrometry in the clinical chemistry laboratory.
    Dooley KC
    Clin Biochem; 2003 Sep; 36(6):471-81. PubMed ID: 12951172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accreditation and Quality Assurance for Clinical Liquid Chromatography-Mass Spectrometry Laboratories.
    Lynch KL
    Clin Lab Med; 2018 Sep; 38(3):515-526. PubMed ID: 30115395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applications of MS-based protein quantification.
    Sabbagh B; Mindt S; Neumaier M; Findeisen P
    Proteomics Clin Appl; 2016 Apr; 10(4):323-45. PubMed ID: 27061318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
    Marquet P
    Ther Drug Monit; 2002 Apr; 24(2):255-76. PubMed ID: 11897972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-performance liquid chromatography-mass spectrometry in the clinical laboratory.
    Taylor PJ
    Ther Drug Monit; 2005 Dec; 27(6):689-93. PubMed ID: 16404795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing.
    Chace DH; Kalas TA
    Clin Biochem; 2005 Apr; 38(4):296-309. PubMed ID: 15766731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MASS SPECTROMETRY ANALYSIS OF DRUGS OF ABUSE: CHALLENGES AND EMERGING STRATEGIES.
    Borden SA; Palaty J; Termopoli V; Famiglini G; Cappiello A; Gill CG; Palma P
    Mass Spectrom Rev; 2020 Sep; 39(5-6):703-744. PubMed ID: 32048319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.
    Monaghan PJ; Keevil BG; Trainer PJ
    Rev Endocr Metab Disord; 2013 Jun; 14(2):143-57. PubMed ID: 23494459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes from tandem mass spectrometry (MS/MS) workshops in the United States and the performance evaluation of MS/MS laboratories.
    Hannon H; Lim T; Adam B; Therrell B
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():121-6. PubMed ID: 15906714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. After another decade: LC-MS/MS became routine in clinical diagnostics.
    Seger C; Salzmann L
    Clin Biochem; 2020 Aug; 82():2-11. PubMed ID: 32188572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories.
    van Belkum A; Welker M; Erhard M; Chatellier S
    J Clin Microbiol; 2012 May; 50(5):1513-7. PubMed ID: 22357505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanded newborn screening by mass spectrometry: New tests, future perspectives.
    Ombrone D; Giocaliere E; Forni G; Malvagia S; la Marca G
    Mass Spectrom Rev; 2016; 35(1):71-84. PubMed ID: 25952022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging flow injection mass spectrometry methods for high-throughput quantitative analysis.
    Nanita SC; Kaldon LG
    Anal Bioanal Chem; 2016 Jan; 408(1):23-33. PubMed ID: 26670771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tandem mass spectrometry: the tool of choice for diagnosing inborn errors of metabolism?
    Clarke S
    Br J Biomed Sci; 2002; 59(1):42-6. PubMed ID: 12000187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.